John Mcpeake analyst ROSENBLATT

Currently out of the existing stock ratings of John Mcpeake, 62 are a BUY (100%).

John Mcpeake

Work Performance Price Targets & Ratings Chart

Analyst John Mcpeake, currently employed at ROSENBLATT, has had 23.08% of price targets met with an average potential upside of 9.41%, reached in 199 days on average.

John Mcpeake has documented 125 price targets and ratings displayed on 10 stocks. The coverage is on the Technology sector.

Most recent stock forecast was given on NBIS, at 13-Nov-2026.

Wall Street Analyst John Mcpeake

Analyst best performing recommendations are on PLTR (PALANTIR TECHNOLOGIES).
The best stock recommendation documented was for PLTR (PALANTIR TECHNOLOGIES) on 2/27/2026. The price target of $150 was fulfilled within 5 days with a profit of $12.81 (9.34%), with a performance score of 18.67.

Average potential price target upside

QBTS D-Wave Quantum PLTR Palantir Technologies IONQ IONQ RGTI Rigetti Computing MSFT Microsoft SNPS Synopsys CRWV NBIS QNT QUBT

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 08-Apr-2024

$20

$13.48 (206.75%)

$40

11 days ago
(11-Nov-2026)

9/15 (60%)

$9.35 (87.79%)

74

Buy Since 04-Aug-2025

$23

$16.48 (252.76%)

$35

11 days ago
(11-Nov-2026)

1/5 (20%)

$12.35 (115.96%)

46

Buy Since 03-Dec-2025

$27

$20.48 (314.11%)

$37

11 days ago
(11-Nov-2026)

0/5 (0%)

$16.35 (153.52%)

Buy Since 07-Nov-2025

$30

$23.48 (360.12%)

$43

11 days ago
(11-Nov-2026)

0/11 (0%)

$19.35 (181.69%)

Buy Since 23-Jul-2025

$31

$24.48 (375.46%)

$41

11 days ago
(11-Nov-2026)

2/6 (33.33%)

$20.35 (191.08%)

22

Show more analysts

Please expand the browser size to see the chart

Which stock is John Mcpeake most bullish on?

Potential upside of $222.69 has been obtained for NBIS

Which stock is John Mcpeake most reserved on?

Potential downside of $17.6 has been obtained for QUBT

What Year was the first public recommendation made by John Mcpeake?

On 2006
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?